These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9119072)
1. Human leukocyte elastase inhibition by Bowman-Birk soybean inhibitor. Discrimination of the inhibition mechanisms. Larionova NI; Gladysheva IP; Gladyshev DP FEBS Lett; 1997 Mar; 404(2-3):245-8. PubMed ID: 9119072 [TBL] [Abstract][Full Text] [Related]
2. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor. Larionova NI; Balabushevitch NG; Zhatikov PA Biochemistry (Mosc); 1998 Sep; 63(9):1078-82. PubMed ID: 9795279 [TBL] [Abstract][Full Text] [Related]
3. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor. Malykh EV; Larionova NI Biochemistry (Mosc); 2002 Dec; 67(12):1383-7. PubMed ID: 12600268 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources. Gladysheva IP; Balabushevich NG; Moroz NA; Larionova NI Biochemistry (Mosc); 2000 Feb; 65(2):198-203. PubMed ID: 10713547 [TBL] [Abstract][Full Text] [Related]
5. [Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibitor]. Larionova NI; Gladysheva IP; Tikhonova TV; Kazanskaia NF Biokhimiia; 1993 Aug; 58(9):1437-44. PubMed ID: 8218567 [TBL] [Abstract][Full Text] [Related]
6. Retardation by the soybean Bowman-Birk inhibitor of elastin hydrolysis catalyzed by leukocyte proteinases. Tikhonova TV; Gladysheva IP; Larionova NI FEBS Lett; 1995 Apr; 362(2):225-8. PubMed ID: 7720877 [TBL] [Abstract][Full Text] [Related]
7. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390 [TBL] [Abstract][Full Text] [Related]
8. [Bowman-Birk soy inhibitor as an affinity ligand for isolating leukocyte elastase. Inhibition of elastin hydrolysis, catalyzed by leukocyte elastase]. Tikhonova TV; Larionova NI; Gladysheva IP; Kazanskaia NF Biokhimiia; 1993 Nov; 58(11):1669-76. PubMed ID: 8268308 [TBL] [Abstract][Full Text] [Related]
9. [Conjugation of classic Bowman-Birk soy inhibitor with a copolymer of ethylene oxide and propylene oxide]. Larionova NI; Gladysheva IP; Topchieva IN; Kazanskaia NF Biokhimiia; 1993 Oct; 58(10):1658-64. PubMed ID: 8268307 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of elastin hydrolysis, catalyzed by human leukocyte elastase and cathepsin G, by the Bowman-Birk type soy inhibitor]. Tikhonova TV; Gladysheva IP; Kazanskaia NF; Larionova NI Biokhimiia; 1994 Nov; 59(11):1739-45. PubMed ID: 7873681 [TBL] [Abstract][Full Text] [Related]
12. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G]. Gladysheva IP; Larionova NI; Gladyshev DP; Tikhonova TV; Kazanskaia NF Biokhimiia; 1994 Apr; 59(4):513-8. PubMed ID: 8018773 [TBL] [Abstract][Full Text] [Related]
13. [High molecular weight soy isoinhibitors of the Bowman-Birk type. Isolation, characteristics, and kinetics of interaction with proteinases]. Gladysheva IP; Sharafutdinov TZ; Larionova NI Bioorg Khim; 1994 Mar; 20(3):281-9. PubMed ID: 8166755 [TBL] [Abstract][Full Text] [Related]
14. The biochemical and functional food properties of the bowman-birk inhibitor. Losso JN Crit Rev Food Sci Nutr; 2008 Jan; 48(1):94-118. PubMed ID: 18274967 [TBL] [Abstract][Full Text] [Related]
15. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type. Gladysheva IP; Zamolodchikova TS; Sokolova EA; Larionova NI Biochemistry (Mosc); 1999 Nov; 64(11):1244-9. PubMed ID: 10611528 [TBL] [Abstract][Full Text] [Related]
16. Anti-chymotrypsin and anti-elastase activities of a synthetic bicyclic fragment containing a chymotrypsin-reactive site of soybean Bowman-Birk inhibitor. Ando S; Yasutake A; Waki M; Nishino N; Kato T; Izumiya N Biochim Biophys Acta; 1987 Dec; 916(3):527-31. PubMed ID: 3689809 [TBL] [Abstract][Full Text] [Related]
17. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Chen YW; Huang SC; Lin-Shiau SY; Lin JK Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161 [TBL] [Abstract][Full Text] [Related]
18. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869 [TBL] [Abstract][Full Text] [Related]
19. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697 [TBL] [Abstract][Full Text] [Related]